Displaying 1 - 1 of 1
| Active Ingredient | VINBLASTINE |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Hodgkins disease, lympomas. |
| Caution | Nausea and vomiting, stomatitis, constipation or diarrhoea, leukopenia. |
| Dose Range | 6 mg/m2, not more often than once every 7 days. Maximum dose 11.1 mg/m2. |
| Drug Interactions | |
| Pregnancy | Vinblastine is not recommended during pregnancy. |
| Breast Feeding | Breastfeeding is not recommended during therapy. |